SciClips

Cancer Biomarker Strategy to Develop Companion Diagnostics for Predicting Prescription Drug Induced. Cancer Biomarker Strategy to Develop Companion Diagnostics for Predicting Prescription Drug Induced Tumors - Analysis using pioglitazone (Actos) and bladder cancer

Recent Patents on Biomarkers Highlights of recent US patents (issued and applications) on protein biomarkers and molecular diagnostics. (Click on titles to view the details) 1. Gene expression biomarker panel for the prognosis...

http://www.sciclips.com/sciclips/bio-protocols.do?catName=Rheumatoid%20arthritis%20%28RA%29%20biomarker%20and%20drug%20discovery%20assay

Rheumatoid arthritis (RA) biomarker and drug discovery assay protocols Rheumatoid arthritis (RA) biomarker and drug discovery assay protocols and methods

Potential Use of Drug Response-Efficacy Biomarkers for Predicting Life-Threatening Disease Causing S Potential Use of Drug Response-Efficacy Biomarkers for Predicting Life-Threatening Disease Causing Side Effects of Therapeutic Drugs

Recent Biomarker Patents Highlights of recent US patents (issued and applications) on protein biomarkers and molecular diagnostics. (Click on titles to view the details) 1. Gene expression markers for the diagnosis of Park...

Strategies for Rational and Personalized Cancer Biomarker Discovery Strategies for Rational and Personalized Cancer Biomarker Discovery

An innovative protocol database for basic cancer research and cancer drug discovery. Link: http://www.sciclips.com/sciclips/bio-protocols.do?catName=Tumor%20and%20tumor%20cell%20assay

Tumor and tumor cell assay protocols Tumor and tumor cell assay protocols and methods

http://sciclips.wordpress.com/2012/02/15/recent-patent-applications-on-next-generation-sequencing/

Recent Patent Applications on Next Generation Sequencing Note: Following are the highlights of recent patent applications on next generation sequencing. Complete review of next generation sequencing related patent searches and data mining are available t...

Sciclips Launches Oncology Biomarker and Companion Diagnostic Pathway Database [Yahoo News]
http://news.yahoo.com/sciclips-launches-oncology-biomarker-companion-diagnostic-pathway-database-081457400.html

Sciclips Launches Oncology Biomarker and Companion Diagnostic Pathway Database Sciclips has launched a comprehensive cancer biomarker database with companion diagnostic pathway maps to meet the growing trend of personalized medicine and advancement in cancer biomarker research.Madison, WI (PRWEB) January 06, 2012 Sciclips, a Madison (WI) based company, has announced the launch...

Tonny Johnson
Cancer Theranostics - Potential Applications of Cancer Biomarker Database
This blog analyzes the potential applications of biomarkers in cancer theranostics (Rx/Dx), a diagnostic therapy process that leads to the development of successful personalized medicine strategies in cancer treatment. Please follow this ink to read this blog: http://sciclips.wordpress.com/2012/01/09/cancer-theranostics-potential-applications-of-cancer-biomarker-database/

Cancer Theranostics – Potential Applications of Cancer Biomarker Database Availability of a comprehensive cancer biomarker database may opens up scientific and technical opportunities in developing innovative oncologic theranostics (Rx/Dx), a diagnostic therapy process t...

Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Liabilities

This blog critically analyzes the potential scientific limitations, risks and liabilities of cell based reporter assays, including non-natural protein based reporter assays (e.g. circularly permuted firefly luciferase or GFP based reporter assays) and stem cell based assays, in drug discovery and development. Scientific arguments have been put forward to suggest that current format of cell based reporter assays may not be ideal for replacing animal studies. This blog also analyzes the potential negative impact of patents and intellectual property (IP) rights in fostering innovations in cell based assays. Finally, this blog warrants imposing accountability, tighter regulations and demanding higher standards in cell based assays that are used in drug discovery and development. Please follow this link to read the full blog article: http://sciclips.wordpress.com/2012/01/16/cell-based-reporter-assays-vs-animal-studies-in-drug-discovery-potential-limitations-risks-and-liabilities/

Cell Based Reporter Assays vs. Animal Studies in Drug Discovery- Potential Limitations, Risks and Li This blog critically analyzes the potential scientific limitations, risks and liabilities of cell based reporter assays, including non-natural protein based reporter assays (e.g. circularly permute...

Highlights of recent stem cell patents issued on Sept.20, 2011 (US patents) and patent applications published on Sept.15, 2011 (US and WO (PCT)).

1. Marker for determining the susceptibility of a cancer patient to an osteoblastic response in mesenchymal stem cells
2.Treating radiation damage using genetically modified mesenchymal stem cells
3. Anti-apoptotic protein STC-1 expressing stem cells for the treatment of prostate cancer
4. Treating leukemia using PTH/PTHrP receptor antagonists that increase the normal hematopoietic stem cells
5. Method for isolating breast cancer stem cells

Details: http://www.sciclips.com/sciclips/drug-discovery-news.do

Drug discovery news Drug discovery news